Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2025 Earnings Call Transcript May 13, 2025
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.41, expectations were $-0.74.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio First Quarter 2025 Financial Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] This call is being recorded today, Tuesday, May, 13, 2025. I would now like to turn the...
